SCHEMBL2655987

SCHEMBL2655987

CCCOc1cc(Oc2ncc(C(=O)N3CCC3)cc2Cl)cc(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 1/20 0.53
KCNH2 Q12809 1/20 0.53
HPGD P15428 3/20 0.42
HSD17B10 Q99714 2/20 0.42
PLA2G2A P14555 1/20 0.42
ALDH1A1 P00352 5/20 0.41
KMT2A Q03164 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
LIPE Q05469 1/20 0.41
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
CRHBP P24387 1/20 0.38
HTT P42858 1/20 0.38
CRHR2 Q13324 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1427058 0.85 GCK (0.58) GCKKCNH2KMT2AMEN1GAA
SCHEMBL2667106 0.84 GCK (0.49) GCKKCNH2HPGDKMT2AMEN1
SCHEMBL2656648 0.84 GCK (0.76) GCKKCNH2ALDH1A1SMN1; SMN2LMNA
SCHEMBL2655781 0.84 GCK (0.62) GCKKCNH2KMT2A
SCHEMBL1427136 0.84 GCK (0.74) GCKKCNH2
SCHEMBL1427062 0.83 GCK (0.62) GCKKCNH2LIPEHRH3
SCHEMBL1652809 0.83 GCK (0.62) GCKKCNH2LIPEHRH3
SCHEMBL2654698 0.83 GCK (0.53) GCKKCNH2KMT2AMEN1LIPE
SCHEMBL1427115 0.82 GCK (0.54) GCKKCNH2HPGDKMT2AMEN1
SCHEMBL1376580 0.82 GCK (0.74) GCKKCNH2HPGDHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902052-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES AstraZeneca AB (SE) 2008-03-26 EP disclosed
WO-2007007041-A1 HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES ASTRAZENECA AB (SE) 2007-01-18 WO disclosed